Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,131,760
-$184,040 QoQ
Shares Held
47,000
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,258
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. PFE ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,282 | $5,858,682 | |
| 2 | JNJ |
Johnson & Johnson
|
22,661 | $5,755,214 | |
| 3 | LLY |
ELI LILLY & Co
|
3,896 | $4,672,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,805 | $1,516,942 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,313 | $1,400,915 | |
| 6 | AMGN |
Amgen Inc
|
3,385 | $1,225,776 | |
| 7 | PFE |
Pfizer Inc
This page
|
47,000 | $1,131,760 | |
| 8 | NVO |
Novo Nordisk A S
|
21,612 | $1,036,079 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,131,760 | 47,000 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,315,800 | 46,859 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,173,063 | 47,111 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,221,995 | 47,959 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,214,593 | 50,107 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,471,341 | 58,064 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,363,986 | 51,413 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,208,592 | 41,762 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,143,906 | 40,883 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,096,902 | 39,528 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,124,882 | 39,072 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,783,749 | 53,776 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,155,243 | 58,758 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,437,147 | 59,734 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,972,996 | 58,021 | Shares | Sole | 2023-03-13 | |
| 2022-09-30 | $2,372,448 | 54,215 | Shares | Sole | 2022-11-18 | |
| 2022-06-30 | $2,842,492 | 54,215 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,801,688 | 54,118 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,195,667 | 54,118 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,311,185 | 53,736 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,081,040 | 53,142 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,945,913 | 53,710 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,952,144 | 53,033 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,176,711 | 59,311 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,913,050 | 58,503 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,889,102 | 57,877 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||